InvestorsHub Logo
Followers 16
Posts 1145
Boards Moderated 0
Alias Born 03/12/2010

Re: None

Tuesday, 04/18/2017 10:44:32 AM

Tuesday, April 18, 2017 10:44:32 AM

Post# of 63
Announces Dosing of First Patient in Investigator-Sponsored Phase 1b/2 Clinical Trial Evaluating Immuno-Oncology Candidate Targeting Incurable HPV-Related Cancers

http://www.marketwired.com/press-release/immunovaccine-announces-dosing-first-patient-investigator-sponsored-phase-1b-2-clinical-tsx-imv-2210107.htm
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y